Search This Blog

Monday, June 1, 2026

Wells Fargo upgrades Tandem Diabetes Care to Overweight

 

Wells Fargo upgrades Tandem Diabetes Care to Overweight from Equal Weight, raises price target to $27

  • Wells Fargo cites Tandem’s pharmacy and pay-as-you-go model progressing faster than expected as upgrade rationale.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.